$MDRX
Veradigm Inc.

2014 Q1 Form 10-Q Financial Statement

#000119312514192417 Filed on May 09, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $340.3M $347.1M
YoY Change -1.95% -4.84%
Cost Of Revenue $202.1M $212.6M
YoY Change -4.96% 1.72%
Gross Profit $138.2M $134.4M
YoY Change 2.8% -13.65%
Gross Profit Margin 40.61% 38.73%
Selling, General & Admin $89.95M $104.2M
YoY Change -13.71% 7.11%
% of Gross Profit 65.09% 77.54%
Research & Development $52.31M $50.66M
YoY Change 3.25% 40.24%
% of Gross Profit 37.85% 37.68%
Depreciation & Amortization $45.13M $42.00M
YoY Change 7.45% 19.26%
% of Gross Profit 32.66% 31.24%
Operating Expenses $142.3M $154.9M
YoY Change -8.16% 16.08%
Operating Profit -$11.91M -$28.28M
YoY Change -57.89% -317.85%
Interest Expense $7.233M $4.637M
YoY Change 55.98% 20.32%
% of Operating Profit
Other Income/Expense, Net -$32.00K $8.131M
YoY Change -100.39% 1932.75%
Pretax Income -$19.18M -$24.79M
YoY Change -22.64% -360.36%
Income Tax $1.566M -$13.20M
% Of Pretax Income
Net Earnings -$20.74M -$11.59M
YoY Change 78.93% -299.42%
Net Earnings / Revenue -6.1% -3.34%
Basic Earnings Per Share -$0.12 -$0.07
Diluted Earnings Per Share -$0.12 -$0.07
COMMON SHARES
Basic Shares Outstanding 179.0M 173.7M shares
Diluted Shares Outstanding 179.0M 173.7M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.60M $92.20M
YoY Change -54.88% -47.52%
Cash & Equivalents $41.58M $92.23M
Short-Term Investments
Other Short-Term Assets $158.7M $175.3M
YoY Change -9.47% 3.12%
Inventory
Prepaid Expenses
Receivables $341.6M $351.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $541.9M $619.3M
YoY Change -12.51% -13.79%
LONG-TERM ASSETS
Property, Plant & Equipment $168.0M $162.3M
YoY Change 3.52% 20.77%
Goodwill $1.191B $1.190B
YoY Change 0.07%
Intangibles $494.1M $556.1M
YoY Change -11.16%
Long-Term Investments $1.300M $1.700M
YoY Change -23.53% 0.0%
Other Assets $197.9M $45.17M
YoY Change 338.02% -43.68%
Total Long-Term Assets $2.092B $2.004B
YoY Change 4.44% 9.29%
TOTAL ASSETS
Total Short-Term Assets $541.9M $619.3M
Total Long-Term Assets $2.092B $2.004B
Total Assets $2.634B $2.623B
YoY Change 0.44% 2.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $68.96M $73.01M
YoY Change -5.54% 21.48%
Accrued Expenses $82.25M $94.09M
YoY Change -12.59% -26.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $19.10M $85.25M
YoY Change -77.6% 76.14%
Total Short-Term Liabilities $529.1M $627.3M
YoY Change -15.66% 13.09%
LONG-TERM LIABILITIES
Long-Term Debt $529.8M $458.6M
YoY Change 15.52% 55.35%
Other Long-Term Liabilities $155.8M $66.08M
YoY Change 135.72% -24.99%
Total Long-Term Liabilities $685.5M $524.7M
YoY Change 30.65% 36.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $529.1M $627.3M
Total Long-Term Liabilities $685.5M $524.7M
Total Liabilities $1.327B $1.289B
YoY Change 2.96% 21.32%
SHAREHOLDERS EQUITY
Retained Earnings -$142.3M -$29.12M
YoY Change 388.63%
Common Stock $2.641M $2.618M
YoY Change 0.88%
Preferred Stock
YoY Change
Treasury Stock (at cost) $278.0M $278.0M
YoY Change 0.0%
Treasury Stock Shares 84.67M shares 84.67M shares
Shareholders Equity $1.308B $1.334B
YoY Change
Total Liabilities & Shareholders Equity $2.634B $2.623B
YoY Change 0.44% 2.79%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$20.74M -$11.59M
YoY Change 78.93% -299.42%
Depreciation, Depletion And Amortization $45.13M $42.00M
YoY Change 7.45% 19.26%
Cash From Operating Activities $21.30M $39.37M
YoY Change -45.89% -47.23%
INVESTING ACTIVITIES
Capital Expenditures $11.95M $16.44M
YoY Change -27.32% -15.38%
Acquisitions $0.00 $148.8M
YoY Change -100.0%
Other Investing Activities -$5.900M -$136.3M
YoY Change -95.67%
Cash From Investing Activities -$27.00M -$160.6M
YoY Change -83.19% 391.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.673M -$7.931M
YoY Change -121.09% 440.26%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.80M 109.2M
YoY Change -114.47% -528.46%
NET CHANGE
Cash From Operating Activities 21.30M 39.37M
Cash From Investing Activities -27.00M -160.6M
Cash From Financing Activities -15.80M 109.2M
Net Change In Cash -21.50M -12.04M
YoY Change 78.54% -173.27%
FREE CASH FLOW
Cash From Operating Activities $21.30M $39.37M
Capital Expenditures $11.95M $16.44M
Free Cash Flow $9.355M $22.93M
YoY Change -59.2% -58.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 mdrx Damages Sought Per Violation
DamagesSoughtPerViolation
500
CY2011Q2 mdrx Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2014-05-09
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
179483355 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92228000
CY2014Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
17.19
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264093000 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.0290 pure
CY2014Q1 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.00896 pure
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
349000000 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
84672000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179421000 shares
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
28769000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
50625000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
529104000
CY2014Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1100000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1704000
CY2014Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18200000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53156000
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
529755000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1727017000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
68962000
CY2014Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10000000
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
155762000
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
19139000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
1307620000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142298000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
305602000
CY2014Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
626563000
CY2014Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
345000000
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82245000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
39375000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
51285000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
149375000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
28125000
CY2014Q1 us-gaap Long Term Debt
LongTermDebt
548480000
CY2014Q1 us-gaap Liabilities
Liabilities
1326618000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
14063000
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
599980000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
2641000
CY2014Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
300000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2634238000
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
83228000
CY2014Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
-16000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
197850000
CY2014Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1313000
CY2014Q1 us-gaap Goodwill
Goodwill
1190603000
CY2014Q1 us-gaap Cost Method Investments
CostMethodInvestments
4100000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
442053000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
341591000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
72956000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
80196000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
545133000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1716847000
CY2014Q1 us-gaap Goodwill Gross
GoodwillGross
1189585000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
55466000
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
278036000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
168026000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7361000
CY2014Q1 us-gaap Assets
Assets
2634238000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41580000
CY2014Q1 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
52000000
CY2014Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
85177000
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
390053000
CY2014Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
78083000
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
990033000
CY2014Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1242603000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
103218000
CY2014Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
11000000
CY2014Q1 us-gaap Unrecognized Tax Benefits Resulting In Net Operating Loss Carryforward
UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward
4000000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
541855000
CY2014Q1 mdrx Business Acquisition Cash Consideration To Acquire Equity Interest
BusinessAcquisitionCashConsiderationToAcquireEquityInterest
6000000
CY2014Q1 mdrx Common Stock Closing Price
CommonStockClosingPrice
18.03
CY2014Q1 mdrx Value Of Intangible Assets Commercial Agreement
ValueOfIntangibleAssetsCommercialAgreement
1900000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103956000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
263474000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
349000000 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
84672000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
178802000 shares
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
29080000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
517039000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1745000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18300000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
130572000
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
16350000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1318145000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121556000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
251038000
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
641875000
CY2013Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
96499000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
54252000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
561026000
CY2013Q4 us-gaap Liabilities
Liabilities
1301518000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
584194000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2635000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2619663000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
79694000
CY2013Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
3524000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163341000
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1329000
CY2013Q4 us-gaap Goodwill
Goodwill
1189585000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
455971000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
313486000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
55468000
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
278036000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
174013000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7361000
CY2013Q4 us-gaap Assets
Assets
2619663000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62954000
CY2013Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
52000000
CY2013Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
88244000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
403971000
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
80849000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
988165000
CY2013Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1241585000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
107911000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
539819000
CY2010Q4 mdrx Interest Rate Swap Agreements Effective Date
InterestRateSwapAgreementsEffectiveDate
2010-10-29
CY2010Q4 mdrx Interest Rate Swap Agreement Termination Date
InterestRateSwapAgreementTerminationDate
2014-10-31
CY2012Q2 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
400000000
CY2012Q2 mdrx Stock Repurchase Program Additional Stock Repurchased Authorized Amount
StockRepurchaseProgramAdditionalStockRepurchasedAuthorizedAmount
200000000
CY2013Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 Segment
CY2011Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2011Q2 mdrx Stock Repurchase Program Initial Stock Repurchased Authorized Amount
StockRepurchaseProgramInitialStockRepurchasedAuthorizedAmount
200000000
CY2014Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2600000 shares
CY2013 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008 pure
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173710000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.559 pure
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.72
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
39366000
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.532 pure
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3668000 shares
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173710000 shares
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16435000
CY2013Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
7871000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
27031000
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11592000
CY2013Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
148802000
CY2013Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
27614000
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
14080000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8131000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1654000
CY2013Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4000
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11592000
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
61084000
CY2013Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1648000
CY2013Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
353000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24789000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-739000
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10905000
CY2013Q1 us-gaap Maintenance Revenue
MaintenanceRevenue
117708000
CY2013Q1 us-gaap Revenues
Revenues
347066000
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12832000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12110000
CY2013Q1 us-gaap Gross Profit
GrossProfit
134428000
CY2013Q1 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28283000
CY2013Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
217000
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8575000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-11592000
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
182000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-518000
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-6000
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
212638000
CY2013Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
12516000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
109184000
CY2013Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
849000
CY2013Q1 us-gaap Maintenance Costs
MaintenanceCosts
36597000
CY2013Q1 us-gaap Cost Of Services
CostOfServices
57582000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8004000
CY2013Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
13329000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11728000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-160592000
CY2013Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3337000
CY2013Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
104232000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13197000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
314000
CY2013Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-359000
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
35462000
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7616000
CY2013Q1 us-gaap Interest Expense
InterestExpense
4637000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21735000
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7931000
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1746000
CY2013Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
129043000
CY2013Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
319000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41997000
CY2013Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
136000
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1300000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1654000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8004000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50659000
CY2013Q1 mdrx Transaction Processing And Other
TransactionProcessingAndOther
141243000
CY2013Q1 mdrx Transaction Processing And Other Cost
TransactionProcessingAndOtherCost
85591000
CY2013Q1 mdrx Shares Withheld To Satisfy Employees Tax Withholding Shares
SharesWithheldToSatisfyEmployeesTaxWithholdingShares
125000 shares
CY2014Q1 dei Trading Symbol
TradingSymbol
MDRX
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
CY2013Q1 mdrx Gain Loss On Change In Fair Value Of Convertible Notes
GainLossOnChangeInFairValueOfConvertibleNotes
0
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001124804
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2014Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2020-07-01
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
179033000 shares
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
21288000
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.082 pure
CY2014Q1 us-gaap Loss Contingency Allegations
LossContingencyAllegations
Counterclaims against Pegasus for breach of two license agreements, breach of warranty, breach of a settlement and arbitration agreement, and three counts of negligent misrepresentation
CY2014Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0275 pure
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
600000 shares
CY2014Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21721000 shares
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 18px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.</font></p> </div>
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.03
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179033000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1990000 shares
CY2014Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
9 Segment
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11945000
CY2014Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
9144000
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
23389000
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20742000
CY2014Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0
CY2014Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2014Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
30313000
CY2014Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-4398000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-32000
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1132000
CY2014Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2000
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20742000
CY2014Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5968000
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
50364000
CY2014Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3184000
CY2014Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
166000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19176000
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28178000
CY2014Q1 us-gaap Maintenance Revenue
MaintenanceRevenue
117077000
CY2014Q1 us-gaap Revenues
Revenues
340285000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2363000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20701000
CY2014Q1 us-gaap Gross Profit
GrossProfit
138186000
CY2014Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1407000
CY2014Q1 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11911000
CY2014Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
123000000
CY2014Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
100000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-20742000
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
110000
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
41000
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-33000
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
202099000
CY2014Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
19000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-15802000
CY2014Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1018000
CY2014Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-27027000
CY2014Q1 us-gaap Maintenance Costs
MaintenanceCosts
35720000
CY2014Q1 us-gaap Cost Of Services
CostOfServices
47900000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10070000
CY2014Q1 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
7983000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-21374000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-26983000
CY2014Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3957000
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2766000
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89946000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1566000
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
123000
CY2014Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-199000
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
54248000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14255000
CY2014Q1 us-gaap Interest Expense
InterestExpense
7233000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-889000
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1673000
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000
CY2014Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2014Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4353000
CY2014Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000
CY2014Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
195000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45127000
CY2014Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
66000
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
510000
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1132000
CY2014Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10070000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52305000
CY2014Q1 mdrx Transaction Processing And Other
TransactionProcessingAndOther
149455000
CY2014Q1 mdrx Transaction Processing And Other Cost
TransactionProcessingAndOtherCost
89465000
CY2014Q1 mdrx Shares Withheld To Satisfy Employees Tax Withholding Shares
SharesWithheldToSatisfyEmployeesTaxWithholdingShares
174000 shares
CY2014Q1 mdrx Gain Loss On Change In Fair Value Of Convertible Notes
GainLossOnChangeInFairValueOfConvertibleNotes
-56000
CY2014Q1 mdrx Cumulative Operating Income Loss Period
CumulativeOperatingIncomeLossPeriod
P3Y
CY2013Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0

Files In Submission

Name View Source Status
0001193125-14-192417-index-headers.html Edgar Link pending
0001193125-14-192417-index.html Edgar Link pending
0001193125-14-192417.txt Edgar Link pending
0001193125-14-192417-xbrl.zip Edgar Link pending
d694729d10q.htm Edgar Link pending
d694729dex101.htm Edgar Link pending
d694729dex311.htm Edgar Link pending
d694729dex312.htm Edgar Link pending
d694729dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdrx-20140331.xml Edgar Link completed
mdrx-20140331.xsd Edgar Link pending
mdrx-20140331_cal.xml Edgar Link unprocessable
mdrx-20140331_def.xml Edgar Link unprocessable
mdrx-20140331_lab.xml Edgar Link unprocessable
mdrx-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending